URSULA
VERDALLÉS GUZMÁN
Profesora asociada de Ciencias de la Salud
MARÍA DE LOS ÁNGELES
GOICOECHEA DIEZHANDINO
Profesora asociada de Ciencias de la Salud
Publications dans lesquelles il/elle collabore avec MARÍA DE LOS ÁNGELES GOICOECHEA DIEZHANDINO (50)
2024
-
Renin–angiotensin–aldosterone system blockers effect in chronic kidney disease progression in hypertensive elderly patients without proteinuria: PROERCAN trial
Hipertensión y riesgo vascular, Vol. 41, Núm. 2, pp. 95-103
-
Tubular biomarkers and histology in lupus nephritis
International Journal of Rheumatic Diseases, Vol. 27, Núm. 6
-
Tubular biomarkers in proteinuric kidney disease: histology correlation and kidney prognosis of tubular biomarkers
Clinical Kidney Journal, Vol. 17, Núm. 5
2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
Obesity, chronic kidney disease progression and the role of the adipokine C1q/TNF related protein-3
Nefrologia, Vol. 43, Núm. 3, pp. 328-334
2021
-
A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?
Kidney International
-
Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching
Hipertension y Riesgo Vascular, Vol. 38, Núm. 2, pp. 63-71
-
Renal long-term outcome of critically ill COVID-19 patients with acute kidney failure and continuous renal replacement therapy
Clinical Kidney Journal
-
Riesgo relacionado con la obesidad para la progresión de insuficiencia renal crónica y enfermedad cardiovascular tras emparejamiento por puntaje de propensión
Hipertensión y riesgo vascular, Vol. 38, Núm. 2, pp. 63-71
-
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Kidney International, Vol. 99, Núm. 4, pp. 986-998
-
Use of renin–angiotensin–aldosterone system blockade in controversial chronic kidney disease populations
Medicina Clinica, Vol. 156, Núm. 11, pp. 561-567
2020
-
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain
Kidney International
-
Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists
Nefrologia, Vol. 40, Núm. 1, pp. 66-74
-
Progresión de la enfermedad renal crónica en pacientes con hipertensión resistente sometidos a 2 estrategias terapéuticas: intensificación con diuréticos de asa vs. antagonistas de la aldosterona
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 40, Núm. 1, pp. 65-73
-
The effect of renin–angiotensin–aldosterone system blockers on the progression of chronic kidney disease in hypertensive elderly patients without proteinuria: PROERCAN study. Rationale and design
Hipertensión y riesgo vascular, Vol. 37, Núm. 3, pp. 101-107
2019
-
An old disease, a new diagnosis; A 49 year-old man with nephrotic syndrome
Journal of Nephropathology, Vol. 8, Núm. 3
-
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 2, pp. 128-139
-
Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 420-426
-
Pentoxifylline, progression of chronic kidney disease (CKD) and cardiovascular mortality: long-term follow-up of a randomized clinical trial
Journal of Nephrology, Vol. 32, Núm. 4, pp. 581-587
2018
-
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)
Cardiovascular Drugs and Therapy, Vol. 32, Núm. 3, pp. 255-263